07:00 , Jul 17, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Pain Sphingosine 1-phosphate receptor 1 (S1PR1; S1P1; EDG1) In vitro and rat studies suggest inhibiting S1PR1 could help treat chemotherapy-induced peripheral neuropathy. In rats treated...